+关注
摩尔拉雅
暂无个人介绍
IP属地:未知
1
关注
1
粉丝
1
主题
0
勋章
主贴
热门
摩尔拉雅
2021-10-28
$腾盛博药-B(02137)$
30块的成本,被套了,但长线看好,中国新冠药物看腾盛了,指望老美是死翘翘的,不卡你脖子都阿弥陀佛了
摩尔拉雅
2021-10-04
$腾盛博药-B(02137)$
市场情绪太差,尤其是美股疫苗周五跌太多,被错杀了
摩尔拉雅
2022-01-25
$腾盛博药-B(02137)$
默沙东和辉瑞的药根本没啥效果,副作用也很大,对肾脏不好,很難成为主流药物
摩尔拉雅
2022-03-01
$腾盛博药-B(02137)$
等了那么久,终于转灯了,坐等药物上线
摩尔拉雅
2022-03-01
$中国人寿(LFC)$
到底什么情况
摩尔拉雅
2022-01-25
$中国人寿(LFC)$
稳啊
摩尔拉雅
2021-12-22
$中电控股(00002)$
只能看看
摩尔拉雅
2021-12-22
看看
@港股研究社:中电控股Q2收入407.29亿港元,同比增加5.24%
摩尔拉雅
2021-11-23
不是吧
@快手抄底王:
$联想控股(03396)$
柳传志是汉奸
摩尔拉雅
2021-11-23
$联想控股(03396)$
有想法?
摩尔拉雅
2021-11-23
$安山金控(00033)$
没人了?
摩尔拉雅
2021-10-28
这篇文章不错,转发给大家看
@雷递:先通医药完成3.2亿元融资 国寿大健康基金和大钲资本领投
摩尔拉雅
2021-10-28
这篇文章不错,转发给大家看
@紫荆财智:国寿走势转强可续跟进
摩尔拉雅
2021-10-04
这篇文章不错,转发给大家看
抱歉,原内容已删除
摩尔拉雅
2021-10-04
应该应该吧
抱歉,原内容已删除
摩尔拉雅
2021-10-04
是吗?
抱歉,原内容已删除
去老虎APP查看更多动态
{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"4090325469879100","uuid":"4090325469879100","gmtCreate":1627222405758,"gmtModify":1627227095463,"name":"摩尔拉雅","pinyin":"melymoerlaya","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/108215f4a8df4e441e706ff3b91022fa","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":1,"headSize":1,"tweetSize":16,"questionSize":0,"limitLevel":999,"accountStatus":2,"level":{"id":2,"name":"无畏虎","nameTw":"無畏虎","represent":"初生牛犊","factor":"发布3条非转发主帖,1条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":1,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.12.09","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001}],"userBadgeCount":1,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":636741362,"gmtCreate":1646118718801,"gmtModify":1646118718801,"author":{"id":"4090325469879100","authorId":"4090325469879100","name":"摩尔拉雅","avatar":"https://static.tigerbbs.com/108215f4a8df4e441e706ff3b91022fa","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090325469879100","authorIdStr":"4090325469879100"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/02137\">$腾盛博药-B(02137)$</a>等了那么久,终于转灯了,坐等药物上线","listText":"<a href=\"https://laohu8.com/S/02137\">$腾盛博药-B(02137)$</a>等了那么久,终于转灯了,坐等药物上线","text":"$腾盛博药-B(02137)$等了那么久,终于转灯了,坐等药物上线","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/636741362","isVote":1,"tweetType":1,"viewCount":1183,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":636743761,"gmtCreate":1646118651289,"gmtModify":1646118651289,"author":{"id":"4090325469879100","authorId":"4090325469879100","name":"摩尔拉雅","avatar":"https://static.tigerbbs.com/108215f4a8df4e441e706ff3b91022fa","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090325469879100","authorIdStr":"4090325469879100"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/LFC\">$中国人寿(LFC)$</a>到底什么情况","listText":"<a href=\"https://laohu8.com/S/LFC\">$中国人寿(LFC)$</a>到底什么情况","text":"$中国人寿(LFC)$到底什么情况","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/636743761","isVote":1,"tweetType":1,"viewCount":1257,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":639062310,"gmtCreate":1643088892676,"gmtModify":1643088892676,"author":{"id":"4090325469879100","authorId":"4090325469879100","name":"摩尔拉雅","avatar":"https://static.tigerbbs.com/108215f4a8df4e441e706ff3b91022fa","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090325469879100","authorIdStr":"4090325469879100"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/02137\">$腾盛博药-B(02137)$</a>默沙东和辉瑞的药根本没啥效果,副作用也很大,对肾脏不好,很難成为主流药物","listText":"<a href=\"https://laohu8.com/S/02137\">$腾盛博药-B(02137)$</a>默沙东和辉瑞的药根本没啥效果,副作用也很大,对肾脏不好,很難成为主流药物","text":"$腾盛博药-B(02137)$默沙东和辉瑞的药根本没啥效果,副作用也很大,对肾脏不好,很難成为主流药物","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/639062310","isVote":1,"tweetType":1,"viewCount":1401,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":639062993,"gmtCreate":1643088872126,"gmtModify":1643088872126,"author":{"id":"4090325469879100","authorId":"4090325469879100","name":"摩尔拉雅","avatar":"https://static.tigerbbs.com/108215f4a8df4e441e706ff3b91022fa","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090325469879100","authorIdStr":"4090325469879100"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/LFC\">$中国人寿(LFC)$</a>稳啊","listText":"<a href=\"https://laohu8.com/S/LFC\">$中国人寿(LFC)$</a>稳啊","text":"$中国人寿(LFC)$稳啊","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/639062993","isVote":1,"tweetType":1,"viewCount":1058,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691183952,"gmtCreate":1640149178699,"gmtModify":1640149178699,"author":{"id":"4090325469879100","authorId":"4090325469879100","name":"摩尔拉雅","avatar":"https://static.tigerbbs.com/108215f4a8df4e441e706ff3b91022fa","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090325469879100","authorIdStr":"4090325469879100"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/00002\">$中电控股(00002)$</a>只能看看","listText":"<a href=\"https://laohu8.com/S/00002\">$中电控股(00002)$</a>只能看看","text":"$中电控股(00002)$只能看看","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/691183952","isVote":1,"tweetType":1,"viewCount":1119,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691183043,"gmtCreate":1640149160999,"gmtModify":1640149160999,"author":{"id":"4090325469879100","authorId":"4090325469879100","name":"摩尔拉雅","avatar":"https://static.tigerbbs.com/108215f4a8df4e441e706ff3b91022fa","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090325469879100","authorIdStr":"4090325469879100"},"themes":[],"htmlText":"看看","listText":"看看","text":"看看","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/691183043","repostId":"804640704","repostType":1,"repost":{"id":804640704,"gmtCreate":1627955620708,"gmtModify":1627955729447,"author":{"id":"3516422794850265","authorId":"3516422794850265","name":"港股研究社","avatar":"https://static.tigerbbs.com/6f93253ece299c58b5ce6c809885d9ed","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3516422794850265","authorIdStr":"3516422794850265"},"themes":[],"title":"中电控股Q2收入407.29亿港元,同比增加5.24%","htmlText":"港股研究社获悉,据智通财经消息,中电控股<a target=\"_blank\" href=\"https://laohu8.com/S/00002\">$中电控股(00002)$</a> 发布公布,于2021年1月1日至2021年6月30日,公司收入407.29亿港元,同比增加5.24%,股东应占盈利46.15亿港元,同比下降23.21%;每股盈利1.83港元;及宣派第二期中期股息每股0.63港元。据财报数据显示,2021年上半年,集团的营运盈利为56.98亿港元,较2020年同期下跌7.0%。继澳洲业务就一宗长时间的诉讼达成和解而取得一次性的支出,以及雅洛恩煤矿场近期受极端降雨所影响,集团为确保煤矿场安全营运的支销而提拨准备,致使总盈利减少23.2%至46.15亿港元。其他数据方面:期内,香港业务表现稳健,但主要由于中国内地和澳洲业务盈利下降,集团营运盈利减少7.0%至56.98亿港元。计入2015年出售Iona燃气厂所引致的诉讼于2021年3月达成和解,及于6月极端暴雨后为确保雅洛恩煤矿场安全营运而提拨准备,集团首六个月的总盈利减少至46.15亿港元。截至2021年6月30日,中电在中国内地的风电及太阳能光伏发电项目被延迟发放的国家可再生能源补贴金额达21.89亿港元,2020年底为17.74亿港元,预计部分补贴将在下半年发放。2021年上半年,本地售电量为164.21亿度,较2020年同期增加4.4%。住宅用电量因年初的寒流,以及第二季天气较为和暖推高了用电量而上升。截止8月2日盘后,中电控股股价跌0.69%,报78.6港元。本文来源:港股研究社—旨在帮助中国投资者理解世界,专注报道港股企业,对港股感兴趣的朋友赶紧关注我们","listText":"港股研究社获悉,据智通财经消息,中电控股<a target=\"_blank\" href=\"https://laohu8.com/S/00002\">$中电控股(00002)$</a> 发布公布,于2021年1月1日至2021年6月30日,公司收入407.29亿港元,同比增加5.24%,股东应占盈利46.15亿港元,同比下降23.21%;每股盈利1.83港元;及宣派第二期中期股息每股0.63港元。据财报数据显示,2021年上半年,集团的营运盈利为56.98亿港元,较2020年同期下跌7.0%。继澳洲业务就一宗长时间的诉讼达成和解而取得一次性的支出,以及雅洛恩煤矿场近期受极端降雨所影响,集团为确保煤矿场安全营运的支销而提拨准备,致使总盈利减少23.2%至46.15亿港元。其他数据方面:期内,香港业务表现稳健,但主要由于中国内地和澳洲业务盈利下降,集团营运盈利减少7.0%至56.98亿港元。计入2015年出售Iona燃气厂所引致的诉讼于2021年3月达成和解,及于6月极端暴雨后为确保雅洛恩煤矿场安全营运而提拨准备,集团首六个月的总盈利减少至46.15亿港元。截至2021年6月30日,中电在中国内地的风电及太阳能光伏发电项目被延迟发放的国家可再生能源补贴金额达21.89亿港元,2020年底为17.74亿港元,预计部分补贴将在下半年发放。2021年上半年,本地售电量为164.21亿度,较2020年同期增加4.4%。住宅用电量因年初的寒流,以及第二季天气较为和暖推高了用电量而上升。截止8月2日盘后,中电控股股价跌0.69%,报78.6港元。本文来源:港股研究社—旨在帮助中国投资者理解世界,专注报道港股企业,对港股感兴趣的朋友赶紧关注我们","text":"港股研究社获悉,据智通财经消息,中电控股$中电控股(00002)$ 发布公布,于2021年1月1日至2021年6月30日,公司收入407.29亿港元,同比增加5.24%,股东应占盈利46.15亿港元,同比下降23.21%;每股盈利1.83港元;及宣派第二期中期股息每股0.63港元。据财报数据显示,2021年上半年,集团的营运盈利为56.98亿港元,较2020年同期下跌7.0%。继澳洲业务就一宗长时间的诉讼达成和解而取得一次性的支出,以及雅洛恩煤矿场近期受极端降雨所影响,集团为确保煤矿场安全营运的支销而提拨准备,致使总盈利减少23.2%至46.15亿港元。其他数据方面:期内,香港业务表现稳健,但主要由于中国内地和澳洲业务盈利下降,集团营运盈利减少7.0%至56.98亿港元。计入2015年出售Iona燃气厂所引致的诉讼于2021年3月达成和解,及于6月极端暴雨后为确保雅洛恩煤矿场安全营运而提拨准备,集团首六个月的总盈利减少至46.15亿港元。截至2021年6月30日,中电在中国内地的风电及太阳能光伏发电项目被延迟发放的国家可再生能源补贴金额达21.89亿港元,2020年底为17.74亿港元,预计部分补贴将在下半年发放。2021年上半年,本地售电量为164.21亿度,较2020年同期增加4.4%。住宅用电量因年初的寒流,以及第二季天气较为和暖推高了用电量而上升。截止8月2日盘后,中电控股股价跌0.69%,报78.6港元。本文来源:港股研究社—旨在帮助中国投资者理解世界,专注报道港股企业,对港股感兴趣的朋友赶紧关注我们","images":[{"img":"https://static.tigerbbs.com/130be0a9ca037f88f69b749a1b3583a0","width":"687","height":"693"}],"top":1,"highlighted":1,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/804640704","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":2,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":1709,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":875692999,"gmtCreate":1637639495676,"gmtModify":1637639495676,"author":{"id":"4090325469879100","authorId":"4090325469879100","name":"摩尔拉雅","avatar":"https://static.tigerbbs.com/108215f4a8df4e441e706ff3b91022fa","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090325469879100","authorIdStr":"4090325469879100"},"themes":[],"htmlText":"不是吧","listText":"不是吧","text":"不是吧","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/875692999","repostId":"872697344","repostType":1,"repost":{"id":872697344,"gmtCreate":1637498719260,"gmtModify":1637498719260,"author":{"id":"3554843151269467","authorId":"3554843151269467","name":"快手抄底王","avatar":"https://static.tigerbbs.com/9882ecdbb58ceb66dddc323a8ab87a68","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3554843151269467","authorIdStr":"3554843151269467"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/03396\">$联想控股(03396)$</a>柳传志是汉奸","listText":"<a href=\"https://laohu8.com/S/03396\">$联想控股(03396)$</a>柳传志是汉奸","text":"$联想控股(03396)$柳传志是汉奸","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/872697344","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":1389,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":875692092,"gmtCreate":1637639484090,"gmtModify":1637639484090,"author":{"id":"4090325469879100","authorId":"4090325469879100","name":"摩尔拉雅","avatar":"https://static.tigerbbs.com/108215f4a8df4e441e706ff3b91022fa","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090325469879100","authorIdStr":"4090325469879100"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/03396\">$联想控股(03396)$</a>有想法?","listText":"<a href=\"https://laohu8.com/S/03396\">$联想控股(03396)$</a>有想法?","text":"$联想控股(03396)$有想法?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/875692092","isVote":1,"tweetType":1,"viewCount":982,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":875696430,"gmtCreate":1637639459635,"gmtModify":1637639459635,"author":{"id":"4090325469879100","authorId":"4090325469879100","name":"摩尔拉雅","avatar":"https://static.tigerbbs.com/108215f4a8df4e441e706ff3b91022fa","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090325469879100","authorIdStr":"4090325469879100"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/00033\">$安山金控(00033)$</a>没人了?","listText":"<a href=\"https://laohu8.com/S/00033\">$安山金控(00033)$</a>没人了?","text":"$安山金控(00033)$没人了?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/875696430","isVote":1,"tweetType":1,"viewCount":1619,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":855732132,"gmtCreate":1635399908083,"gmtModify":1635402447041,"author":{"id":"4090325469879100","authorId":"4090325469879100","name":"摩尔拉雅","avatar":"https://static.tigerbbs.com/108215f4a8df4e441e706ff3b91022fa","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090325469879100","authorIdStr":"4090325469879100"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/02137\">$腾盛博药-B(02137)$</a>30块的成本,被套了,但长线看好,中国新冠药物看腾盛了,指望老美是死翘翘的,不卡你脖子都阿弥陀佛了","listText":"<a href=\"https://laohu8.com/S/02137\">$腾盛博药-B(02137)$</a>30块的成本,被套了,但长线看好,中国新冠药物看腾盛了,指望老美是死翘翘的,不卡你脖子都阿弥陀佛了","text":"$腾盛博药-B(02137)$30块的成本,被套了,但长线看好,中国新冠药物看腾盛了,指望老美是死翘翘的,不卡你脖子都阿弥陀佛了","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/855732132","isVote":1,"tweetType":1,"viewCount":2375,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":855736172,"gmtCreate":1635399822836,"gmtModify":1635399822836,"author":{"id":"4090325469879100","authorId":"4090325469879100","name":"摩尔拉雅","avatar":"https://static.tigerbbs.com/108215f4a8df4e441e706ff3b91022fa","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090325469879100","authorIdStr":"4090325469879100"},"themes":[],"htmlText":"这篇文章不错,转发给大家看","listText":"这篇文章不错,转发给大家看","text":"这篇文章不错,转发给大家看","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/855736172","repostId":"853292692","repostType":1,"repost":{"id":853292692,"gmtCreate":1634811243715,"gmtModify":1634811243715,"author":{"id":"3520120256277227","authorId":"3520120256277227","name":"雷递","avatar":"https://static.tigerbbs.com/c1d76d196de1b078825d97644631d0f1","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3520120256277227","authorIdStr":"3520120256277227"},"themes":[],"title":"先通医药完成3.2亿元融资 国寿大健康基金和大钲资本领投","htmlText":"雷递网 乐天 10月21日报道北京先通国际医药科技股份有限公司(下称“先通医药”)宣布完成3.2亿元D+轮融资。本轮融资由新进投资机构国寿大健康基金和大钲资本共同投资,现有股东盼亚投资、得怡资本等继续跟投。此前公司刚刚完成D轮融资,自2020年4月至今不到一年半时间,公司连续完成总额约10亿元融资。先通医药称,此次募集资金将继续用于放射性新药项目的临床研究和开发。先通医药是专注新一代放射性药物研发、生产及临床应用的创新型医药企业,深耕放射性靶向诊疗一体化系列丰沛产品线。总部位于首都北京,同时在江苏、广东、四川拥有现代化放射性药物生产基地,美国拥有分支机构。公司依托全球领先的放射性药物和精准诊疗领域研发资源,在肿瘤、神经退行性疾病和心血管等领域已率先布局多款靶向治疗和精准诊断放射性药物;依托自主研发团队强大的研发能力,目前公司管线已布局多个放射性诊断和治疗产品,部分进入注册临床研究阶段。随着近年来放射性同位素的靶向性临床应用,全球放射性药物市场规模增长迅速,2020年为71亿美元,预计2030年将达到260亿美元。与此同时随着国内纲领性产业文件的发布、放射性药物适用于MAH制度、核医学设备配置证的放开,国内的放射药市场也将迎来蓬勃发展。先通医药创始人、董事长徐新盛表示:“随着核医学领域国家中长期发展规划的出台,国内放射性药物领域的发展开始步入快车道。我国的核医学领域尚处在发展早期阶段,先通依靠较强的自主研发能力,同时与国际上的先进核药企业开展合作,全力推进放射药品的研发,为广大患者和核医学界同仁提供充足的弹药。”徐新盛说:“我们相信在优质资本的助力下,与合作伙伴共同努力,将先通打造成国内放射药细分领域的领先企业,为中国放射药行业的崛起贡献一份力量。”———————————————雷递由资深媒体人雷建平创办,若转载请写明来源。","listText":"雷递网 乐天 10月21日报道北京先通国际医药科技股份有限公司(下称“先通医药”)宣布完成3.2亿元D+轮融资。本轮融资由新进投资机构国寿大健康基金和大钲资本共同投资,现有股东盼亚投资、得怡资本等继续跟投。此前公司刚刚完成D轮融资,自2020年4月至今不到一年半时间,公司连续完成总额约10亿元融资。先通医药称,此次募集资金将继续用于放射性新药项目的临床研究和开发。先通医药是专注新一代放射性药物研发、生产及临床应用的创新型医药企业,深耕放射性靶向诊疗一体化系列丰沛产品线。总部位于首都北京,同时在江苏、广东、四川拥有现代化放射性药物生产基地,美国拥有分支机构。公司依托全球领先的放射性药物和精准诊疗领域研发资源,在肿瘤、神经退行性疾病和心血管等领域已率先布局多款靶向治疗和精准诊断放射性药物;依托自主研发团队强大的研发能力,目前公司管线已布局多个放射性诊断和治疗产品,部分进入注册临床研究阶段。随着近年来放射性同位素的靶向性临床应用,全球放射性药物市场规模增长迅速,2020年为71亿美元,预计2030年将达到260亿美元。与此同时随着国内纲领性产业文件的发布、放射性药物适用于MAH制度、核医学设备配置证的放开,国内的放射药市场也将迎来蓬勃发展。先通医药创始人、董事长徐新盛表示:“随着核医学领域国家中长期发展规划的出台,国内放射性药物领域的发展开始步入快车道。我国的核医学领域尚处在发展早期阶段,先通依靠较强的自主研发能力,同时与国际上的先进核药企业开展合作,全力推进放射药品的研发,为广大患者和核医学界同仁提供充足的弹药。”徐新盛说:“我们相信在优质资本的助力下,与合作伙伴共同努力,将先通打造成国内放射药细分领域的领先企业,为中国放射药行业的崛起贡献一份力量。”———————————————雷递由资深媒体人雷建平创办,若转载请写明来源。","text":"雷递网 乐天 10月21日报道北京先通国际医药科技股份有限公司(下称“先通医药”)宣布完成3.2亿元D+轮融资。本轮融资由新进投资机构国寿大健康基金和大钲资本共同投资,现有股东盼亚投资、得怡资本等继续跟投。此前公司刚刚完成D轮融资,自2020年4月至今不到一年半时间,公司连续完成总额约10亿元融资。先通医药称,此次募集资金将继续用于放射性新药项目的临床研究和开发。先通医药是专注新一代放射性药物研发、生产及临床应用的创新型医药企业,深耕放射性靶向诊疗一体化系列丰沛产品线。总部位于首都北京,同时在江苏、广东、四川拥有现代化放射性药物生产基地,美国拥有分支机构。公司依托全球领先的放射性药物和精准诊疗领域研发资源,在肿瘤、神经退行性疾病和心血管等领域已率先布局多款靶向治疗和精准诊断放射性药物;依托自主研发团队强大的研发能力,目前公司管线已布局多个放射性诊断和治疗产品,部分进入注册临床研究阶段。随着近年来放射性同位素的靶向性临床应用,全球放射性药物市场规模增长迅速,2020年为71亿美元,预计2030年将达到260亿美元。与此同时随着国内纲领性产业文件的发布、放射性药物适用于MAH制度、核医学设备配置证的放开,国内的放射药市场也将迎来蓬勃发展。先通医药创始人、董事长徐新盛表示:“随着核医学领域国家中长期发展规划的出台,国内放射性药物领域的发展开始步入快车道。我国的核医学领域尚处在发展早期阶段,先通依靠较强的自主研发能力,同时与国际上的先进核药企业开展合作,全力推进放射药品的研发,为广大患者和核医学界同仁提供充足的弹药。”徐新盛说:“我们相信在优质资本的助力下,与合作伙伴共同努力,将先通打造成国内放射药细分领域的领先企业,为中国放射药行业的崛起贡献一份力量。”———————————————雷递由资深媒体人雷建平创办,若转载请写明来源。","images":[{"img":"https://static.tigerbbs.com/1e412d5fe338ad36aa0a8dde63455c4f"}],"top":1,"highlighted":1,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/853292692","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":851,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":855736346,"gmtCreate":1635399815870,"gmtModify":1635399815870,"author":{"id":"4090325469879100","authorId":"4090325469879100","name":"摩尔拉雅","avatar":"https://static.tigerbbs.com/108215f4a8df4e441e706ff3b91022fa","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090325469879100","authorIdStr":"4090325469879100"},"themes":[],"htmlText":"这篇文章不错,转发给大家看","listText":"这篇文章不错,转发给大家看","text":"这篇文章不错,转发给大家看","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/855736346","repostId":"851122079","repostType":1,"repost":{"id":851122079,"gmtCreate":1634883866090,"gmtModify":1634884068988,"author":{"id":"3556666140891757","authorId":"3556666140891757","name":"紫荆财智","avatar":"https://static.tigerbbs.com/9be2735744f718237d3b5ef362758bb9","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3556666140891757","authorIdStr":"3556666140891757"},"themes":[],"title":"国寿走势转强可续跟进","htmlText":"中资保险股昨日成为市场热捧的焦点之一,尤其是下周三派发成绩表的中国平安(2318),见偷步炒上,收报62.75元,升7.54%,为表现最突出的蓝筹股之一。同属一线内险股的中国人寿(2628)昨日亦跟随同业造好,曾高见14.5元,乃为7月7日以来高位,收报14.28元,仍升0.3元或2.15%,现价已企稳于多条重要平均线之上。国寿已定于下周四(28日)公布第三季业绩,观乎集团最近公布的保费收入保持平稳的增长势头,加上早前派发的中期颇为对办,预计季续也不会令市场失望。国寿较早前公布上半年业绩,录得纯利按年上升34.19%至409.75亿元(人民币,下同),主要由总投资收益上升带动,期内总投资收益率为5.69% ,按年上升0.35个百分点,总投资收益按年上升22.37%至1176.38亿元。至于反映未来盈利能力的新业务价值,按年跌19.04% 至298.67 亿元( 人民币,下同),新单保费按年下跌8.41% 至1,339.14 亿元,主要业务个人保险渠道的新业务价值率,按年下跌3.1 个百分点至36.2% 。国寿解释,外部经营环境复杂多变,加上新冠疫情影响保险消费需求释放,行业复苏发展面临多重挑战。国寿首年期交保费按年下跌14.3% 至806.74 亿元,其中利润较高的10 年期及以上首年期交保费,按年下降26.7% 至289.40 亿元,下跌主要来自寿险业务。最新的营运数据显示,集团首九个月原保费收入为5,534亿元,按年增1.8%。该股预测市盈率5.33倍,低于平保的6.7倍,市账率0.75倍,亦低于平保的1.26倍。在股价走势转好下,其下一个目标将上移至16元(港元,下同),惟失守20天线支持的13.45元则止蚀。看好国寿留意购轮26466若看好国寿后市升势延续,可留意国寿中银购轮(26466)。26466昨收0.241元,其于明年5月16日最后买卖,行使价15.02元,","listText":"中资保险股昨日成为市场热捧的焦点之一,尤其是下周三派发成绩表的中国平安(2318),见偷步炒上,收报62.75元,升7.54%,为表现最突出的蓝筹股之一。同属一线内险股的中国人寿(2628)昨日亦跟随同业造好,曾高见14.5元,乃为7月7日以来高位,收报14.28元,仍升0.3元或2.15%,现价已企稳于多条重要平均线之上。国寿已定于下周四(28日)公布第三季业绩,观乎集团最近公布的保费收入保持平稳的增长势头,加上早前派发的中期颇为对办,预计季续也不会令市场失望。国寿较早前公布上半年业绩,录得纯利按年上升34.19%至409.75亿元(人民币,下同),主要由总投资收益上升带动,期内总投资收益率为5.69% ,按年上升0.35个百分点,总投资收益按年上升22.37%至1176.38亿元。至于反映未来盈利能力的新业务价值,按年跌19.04% 至298.67 亿元( 人民币,下同),新单保费按年下跌8.41% 至1,339.14 亿元,主要业务个人保险渠道的新业务价值率,按年下跌3.1 个百分点至36.2% 。国寿解释,外部经营环境复杂多变,加上新冠疫情影响保险消费需求释放,行业复苏发展面临多重挑战。国寿首年期交保费按年下跌14.3% 至806.74 亿元,其中利润较高的10 年期及以上首年期交保费,按年下降26.7% 至289.40 亿元,下跌主要来自寿险业务。最新的营运数据显示,集团首九个月原保费收入为5,534亿元,按年增1.8%。该股预测市盈率5.33倍,低于平保的6.7倍,市账率0.75倍,亦低于平保的1.26倍。在股价走势转好下,其下一个目标将上移至16元(港元,下同),惟失守20天线支持的13.45元则止蚀。看好国寿留意购轮26466若看好国寿后市升势延续,可留意国寿中银购轮(26466)。26466昨收0.241元,其于明年5月16日最后买卖,行使价15.02元,","text":"中资保险股昨日成为市场热捧的焦点之一,尤其是下周三派发成绩表的中国平安(2318),见偷步炒上,收报62.75元,升7.54%,为表现最突出的蓝筹股之一。同属一线内险股的中国人寿(2628)昨日亦跟随同业造好,曾高见14.5元,乃为7月7日以来高位,收报14.28元,仍升0.3元或2.15%,现价已企稳于多条重要平均线之上。国寿已定于下周四(28日)公布第三季业绩,观乎集团最近公布的保费收入保持平稳的增长势头,加上早前派发的中期颇为对办,预计季续也不会令市场失望。国寿较早前公布上半年业绩,录得纯利按年上升34.19%至409.75亿元(人民币,下同),主要由总投资收益上升带动,期内总投资收益率为5.69% ,按年上升0.35个百分点,总投资收益按年上升22.37%至1176.38亿元。至于反映未来盈利能力的新业务价值,按年跌19.04% 至298.67 亿元( 人民币,下同),新单保费按年下跌8.41% 至1,339.14 亿元,主要业务个人保险渠道的新业务价值率,按年下跌3.1 个百分点至36.2% 。国寿解释,外部经营环境复杂多变,加上新冠疫情影响保险消费需求释放,行业复苏发展面临多重挑战。国寿首年期交保费按年下跌14.3% 至806.74 亿元,其中利润较高的10 年期及以上首年期交保费,按年下降26.7% 至289.40 亿元,下跌主要来自寿险业务。最新的营运数据显示,集团首九个月原保费收入为5,534亿元,按年增1.8%。该股预测市盈率5.33倍,低于平保的6.7倍,市账率0.75倍,亦低于平保的1.26倍。在股价走势转好下,其下一个目标将上移至16元(港元,下同),惟失守20天线支持的13.45元则止蚀。看好国寿留意购轮26466若看好国寿后市升势延续,可留意国寿中银购轮(26466)。26466昨收0.241元,其于明年5月16日最后买卖,行使价15.02元,","images":[{"img":"https://static.tigerbbs.com/01b4136dcc2068934838b7c063139597"}],"top":1,"highlighted":1,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/851122079","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":734,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":820042872,"gmtCreate":1633331940812,"gmtModify":1633331940812,"author":{"id":"4090325469879100","authorId":"4090325469879100","name":"摩尔拉雅","avatar":"https://static.tigerbbs.com/108215f4a8df4e441e706ff3b91022fa","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090325469879100","authorIdStr":"4090325469879100"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/02137\">$腾盛博药-B(02137)$</a>市场情绪太差,尤其是美股疫苗周五跌太多,被错杀了","listText":"<a href=\"https://laohu8.com/S/02137\">$腾盛博药-B(02137)$</a>市场情绪太差,尤其是美股疫苗周五跌太多,被错杀了","text":"$腾盛博药-B(02137)$市场情绪太差,尤其是美股疫苗周五跌太多,被错杀了","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/820042872","isVote":1,"tweetType":1,"viewCount":957,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":820042910,"gmtCreate":1633331871863,"gmtModify":1633331871863,"author":{"id":"4090325469879100","authorId":"4090325469879100","name":"摩尔拉雅","avatar":"https://static.tigerbbs.com/108215f4a8df4e441e706ff3b91022fa","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090325469879100","authorIdStr":"4090325469879100"},"themes":[],"htmlText":"这篇文章不错,转发给大家看","listText":"这篇文章不错,转发给大家看","text":"这篇文章不错,转发给大家看","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/820042910","repostId":"2172396270","repostType":4,"isVote":1,"tweetType":1,"viewCount":307,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":820046762,"gmtCreate":1633331844220,"gmtModify":1633331844220,"author":{"id":"4090325469879100","authorId":"4090325469879100","name":"摩尔拉雅","avatar":"https://static.tigerbbs.com/108215f4a8df4e441e706ff3b91022fa","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090325469879100","authorIdStr":"4090325469879100"},"themes":[],"htmlText":"应该应该吧","listText":"应该应该吧","text":"应该应该吧","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/820046762","repostId":"2172998592","repostType":4,"isVote":1,"tweetType":1,"viewCount":236,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":820046522,"gmtCreate":1633331815586,"gmtModify":1633331815586,"author":{"id":"4090325469879100","authorId":"4090325469879100","name":"摩尔拉雅","avatar":"https://static.tigerbbs.com/108215f4a8df4e441e706ff3b91022fa","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090325469879100","authorIdStr":"4090325469879100"},"themes":[],"htmlText":"是吗?","listText":"是吗?","text":"是吗?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/820046522","repostId":"2172998592","repostType":4,"isVote":1,"tweetType":1,"viewCount":406,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":855732132,"gmtCreate":1635399908083,"gmtModify":1635402447041,"author":{"id":"4090325469879100","authorId":"4090325469879100","name":"摩尔拉雅","avatar":"https://static.tigerbbs.com/108215f4a8df4e441e706ff3b91022fa","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090325469879100","authorIdStr":"4090325469879100"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/02137\">$腾盛博药-B(02137)$</a>30块的成本,被套了,但长线看好,中国新冠药物看腾盛了,指望老美是死翘翘的,不卡你脖子都阿弥陀佛了","listText":"<a href=\"https://laohu8.com/S/02137\">$腾盛博药-B(02137)$</a>30块的成本,被套了,但长线看好,中国新冠药物看腾盛了,指望老美是死翘翘的,不卡你脖子都阿弥陀佛了","text":"$腾盛博药-B(02137)$30块的成本,被套了,但长线看好,中国新冠药物看腾盛了,指望老美是死翘翘的,不卡你脖子都阿弥陀佛了","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/855732132","isVote":1,"tweetType":1,"viewCount":2375,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":820042872,"gmtCreate":1633331940812,"gmtModify":1633331940812,"author":{"id":"4090325469879100","authorId":"4090325469879100","name":"摩尔拉雅","avatar":"https://static.tigerbbs.com/108215f4a8df4e441e706ff3b91022fa","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090325469879100","authorIdStr":"4090325469879100"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/02137\">$腾盛博药-B(02137)$</a>市场情绪太差,尤其是美股疫苗周五跌太多,被错杀了","listText":"<a href=\"https://laohu8.com/S/02137\">$腾盛博药-B(02137)$</a>市场情绪太差,尤其是美股疫苗周五跌太多,被错杀了","text":"$腾盛博药-B(02137)$市场情绪太差,尤其是美股疫苗周五跌太多,被错杀了","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/820042872","isVote":1,"tweetType":1,"viewCount":957,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":639062310,"gmtCreate":1643088892676,"gmtModify":1643088892676,"author":{"id":"4090325469879100","authorId":"4090325469879100","name":"摩尔拉雅","avatar":"https://static.tigerbbs.com/108215f4a8df4e441e706ff3b91022fa","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090325469879100","authorIdStr":"4090325469879100"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/02137\">$腾盛博药-B(02137)$</a>默沙东和辉瑞的药根本没啥效果,副作用也很大,对肾脏不好,很難成为主流药物","listText":"<a href=\"https://laohu8.com/S/02137\">$腾盛博药-B(02137)$</a>默沙东和辉瑞的药根本没啥效果,副作用也很大,对肾脏不好,很難成为主流药物","text":"$腾盛博药-B(02137)$默沙东和辉瑞的药根本没啥效果,副作用也很大,对肾脏不好,很難成为主流药物","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/639062310","isVote":1,"tweetType":1,"viewCount":1401,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":636741362,"gmtCreate":1646118718801,"gmtModify":1646118718801,"author":{"id":"4090325469879100","authorId":"4090325469879100","name":"摩尔拉雅","avatar":"https://static.tigerbbs.com/108215f4a8df4e441e706ff3b91022fa","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090325469879100","authorIdStr":"4090325469879100"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/02137\">$腾盛博药-B(02137)$</a>等了那么久,终于转灯了,坐等药物上线","listText":"<a href=\"https://laohu8.com/S/02137\">$腾盛博药-B(02137)$</a>等了那么久,终于转灯了,坐等药物上线","text":"$腾盛博药-B(02137)$等了那么久,终于转灯了,坐等药物上线","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/636741362","isVote":1,"tweetType":1,"viewCount":1183,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":636743761,"gmtCreate":1646118651289,"gmtModify":1646118651289,"author":{"id":"4090325469879100","authorId":"4090325469879100","name":"摩尔拉雅","avatar":"https://static.tigerbbs.com/108215f4a8df4e441e706ff3b91022fa","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090325469879100","authorIdStr":"4090325469879100"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/LFC\">$中国人寿(LFC)$</a>到底什么情况","listText":"<a href=\"https://laohu8.com/S/LFC\">$中国人寿(LFC)$</a>到底什么情况","text":"$中国人寿(LFC)$到底什么情况","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/636743761","isVote":1,"tweetType":1,"viewCount":1257,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":639062993,"gmtCreate":1643088872126,"gmtModify":1643088872126,"author":{"id":"4090325469879100","authorId":"4090325469879100","name":"摩尔拉雅","avatar":"https://static.tigerbbs.com/108215f4a8df4e441e706ff3b91022fa","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090325469879100","authorIdStr":"4090325469879100"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/LFC\">$中国人寿(LFC)$</a>稳啊","listText":"<a href=\"https://laohu8.com/S/LFC\">$中国人寿(LFC)$</a>稳啊","text":"$中国人寿(LFC)$稳啊","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/639062993","isVote":1,"tweetType":1,"viewCount":1058,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691183952,"gmtCreate":1640149178699,"gmtModify":1640149178699,"author":{"id":"4090325469879100","authorId":"4090325469879100","name":"摩尔拉雅","avatar":"https://static.tigerbbs.com/108215f4a8df4e441e706ff3b91022fa","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090325469879100","authorIdStr":"4090325469879100"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/00002\">$中电控股(00002)$</a>只能看看","listText":"<a href=\"https://laohu8.com/S/00002\">$中电控股(00002)$</a>只能看看","text":"$中电控股(00002)$只能看看","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/691183952","isVote":1,"tweetType":1,"viewCount":1119,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691183043,"gmtCreate":1640149160999,"gmtModify":1640149160999,"author":{"id":"4090325469879100","authorId":"4090325469879100","name":"摩尔拉雅","avatar":"https://static.tigerbbs.com/108215f4a8df4e441e706ff3b91022fa","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090325469879100","authorIdStr":"4090325469879100"},"themes":[],"htmlText":"看看","listText":"看看","text":"看看","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/691183043","repostId":"804640704","repostType":1,"repost":{"id":804640704,"gmtCreate":1627955620708,"gmtModify":1627955729447,"author":{"id":"3516422794850265","authorId":"3516422794850265","name":"港股研究社","avatar":"https://static.tigerbbs.com/6f93253ece299c58b5ce6c809885d9ed","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3516422794850265","authorIdStr":"3516422794850265"},"themes":[],"title":"中电控股Q2收入407.29亿港元,同比增加5.24%","htmlText":"港股研究社获悉,据智通财经消息,中电控股<a target=\"_blank\" href=\"https://laohu8.com/S/00002\">$中电控股(00002)$</a> 发布公布,于2021年1月1日至2021年6月30日,公司收入407.29亿港元,同比增加5.24%,股东应占盈利46.15亿港元,同比下降23.21%;每股盈利1.83港元;及宣派第二期中期股息每股0.63港元。据财报数据显示,2021年上半年,集团的营运盈利为56.98亿港元,较2020年同期下跌7.0%。继澳洲业务就一宗长时间的诉讼达成和解而取得一次性的支出,以及雅洛恩煤矿场近期受极端降雨所影响,集团为确保煤矿场安全营运的支销而提拨准备,致使总盈利减少23.2%至46.15亿港元。其他数据方面:期内,香港业务表现稳健,但主要由于中国内地和澳洲业务盈利下降,集团营运盈利减少7.0%至56.98亿港元。计入2015年出售Iona燃气厂所引致的诉讼于2021年3月达成和解,及于6月极端暴雨后为确保雅洛恩煤矿场安全营运而提拨准备,集团首六个月的总盈利减少至46.15亿港元。截至2021年6月30日,中电在中国内地的风电及太阳能光伏发电项目被延迟发放的国家可再生能源补贴金额达21.89亿港元,2020年底为17.74亿港元,预计部分补贴将在下半年发放。2021年上半年,本地售电量为164.21亿度,较2020年同期增加4.4%。住宅用电量因年初的寒流,以及第二季天气较为和暖推高了用电量而上升。截止8月2日盘后,中电控股股价跌0.69%,报78.6港元。本文来源:港股研究社—旨在帮助中国投资者理解世界,专注报道港股企业,对港股感兴趣的朋友赶紧关注我们","listText":"港股研究社获悉,据智通财经消息,中电控股<a target=\"_blank\" href=\"https://laohu8.com/S/00002\">$中电控股(00002)$</a> 发布公布,于2021年1月1日至2021年6月30日,公司收入407.29亿港元,同比增加5.24%,股东应占盈利46.15亿港元,同比下降23.21%;每股盈利1.83港元;及宣派第二期中期股息每股0.63港元。据财报数据显示,2021年上半年,集团的营运盈利为56.98亿港元,较2020年同期下跌7.0%。继澳洲业务就一宗长时间的诉讼达成和解而取得一次性的支出,以及雅洛恩煤矿场近期受极端降雨所影响,集团为确保煤矿场安全营运的支销而提拨准备,致使总盈利减少23.2%至46.15亿港元。其他数据方面:期内,香港业务表现稳健,但主要由于中国内地和澳洲业务盈利下降,集团营运盈利减少7.0%至56.98亿港元。计入2015年出售Iona燃气厂所引致的诉讼于2021年3月达成和解,及于6月极端暴雨后为确保雅洛恩煤矿场安全营运而提拨准备,集团首六个月的总盈利减少至46.15亿港元。截至2021年6月30日,中电在中国内地的风电及太阳能光伏发电项目被延迟发放的国家可再生能源补贴金额达21.89亿港元,2020年底为17.74亿港元,预计部分补贴将在下半年发放。2021年上半年,本地售电量为164.21亿度,较2020年同期增加4.4%。住宅用电量因年初的寒流,以及第二季天气较为和暖推高了用电量而上升。截止8月2日盘后,中电控股股价跌0.69%,报78.6港元。本文来源:港股研究社—旨在帮助中国投资者理解世界,专注报道港股企业,对港股感兴趣的朋友赶紧关注我们","text":"港股研究社获悉,据智通财经消息,中电控股$中电控股(00002)$ 发布公布,于2021年1月1日至2021年6月30日,公司收入407.29亿港元,同比增加5.24%,股东应占盈利46.15亿港元,同比下降23.21%;每股盈利1.83港元;及宣派第二期中期股息每股0.63港元。据财报数据显示,2021年上半年,集团的营运盈利为56.98亿港元,较2020年同期下跌7.0%。继澳洲业务就一宗长时间的诉讼达成和解而取得一次性的支出,以及雅洛恩煤矿场近期受极端降雨所影响,集团为确保煤矿场安全营运的支销而提拨准备,致使总盈利减少23.2%至46.15亿港元。其他数据方面:期内,香港业务表现稳健,但主要由于中国内地和澳洲业务盈利下降,集团营运盈利减少7.0%至56.98亿港元。计入2015年出售Iona燃气厂所引致的诉讼于2021年3月达成和解,及于6月极端暴雨后为确保雅洛恩煤矿场安全营运而提拨准备,集团首六个月的总盈利减少至46.15亿港元。截至2021年6月30日,中电在中国内地的风电及太阳能光伏发电项目被延迟发放的国家可再生能源补贴金额达21.89亿港元,2020年底为17.74亿港元,预计部分补贴将在下半年发放。2021年上半年,本地售电量为164.21亿度,较2020年同期增加4.4%。住宅用电量因年初的寒流,以及第二季天气较为和暖推高了用电量而上升。截止8月2日盘后,中电控股股价跌0.69%,报78.6港元。本文来源:港股研究社—旨在帮助中国投资者理解世界,专注报道港股企业,对港股感兴趣的朋友赶紧关注我们","images":[{"img":"https://static.tigerbbs.com/130be0a9ca037f88f69b749a1b3583a0","width":"687","height":"693"}],"top":1,"highlighted":1,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/804640704","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":2,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":1709,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":875692999,"gmtCreate":1637639495676,"gmtModify":1637639495676,"author":{"id":"4090325469879100","authorId":"4090325469879100","name":"摩尔拉雅","avatar":"https://static.tigerbbs.com/108215f4a8df4e441e706ff3b91022fa","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090325469879100","authorIdStr":"4090325469879100"},"themes":[],"htmlText":"不是吧","listText":"不是吧","text":"不是吧","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/875692999","repostId":"872697344","repostType":1,"repost":{"id":872697344,"gmtCreate":1637498719260,"gmtModify":1637498719260,"author":{"id":"3554843151269467","authorId":"3554843151269467","name":"快手抄底王","avatar":"https://static.tigerbbs.com/9882ecdbb58ceb66dddc323a8ab87a68","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3554843151269467","authorIdStr":"3554843151269467"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/03396\">$联想控股(03396)$</a>柳传志是汉奸","listText":"<a href=\"https://laohu8.com/S/03396\">$联想控股(03396)$</a>柳传志是汉奸","text":"$联想控股(03396)$柳传志是汉奸","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/872697344","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":1389,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":875692092,"gmtCreate":1637639484090,"gmtModify":1637639484090,"author":{"id":"4090325469879100","authorId":"4090325469879100","name":"摩尔拉雅","avatar":"https://static.tigerbbs.com/108215f4a8df4e441e706ff3b91022fa","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090325469879100","authorIdStr":"4090325469879100"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/03396\">$联想控股(03396)$</a>有想法?","listText":"<a href=\"https://laohu8.com/S/03396\">$联想控股(03396)$</a>有想法?","text":"$联想控股(03396)$有想法?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/875692092","isVote":1,"tweetType":1,"viewCount":982,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":875696430,"gmtCreate":1637639459635,"gmtModify":1637639459635,"author":{"id":"4090325469879100","authorId":"4090325469879100","name":"摩尔拉雅","avatar":"https://static.tigerbbs.com/108215f4a8df4e441e706ff3b91022fa","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090325469879100","authorIdStr":"4090325469879100"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/00033\">$安山金控(00033)$</a>没人了?","listText":"<a href=\"https://laohu8.com/S/00033\">$安山金控(00033)$</a>没人了?","text":"$安山金控(00033)$没人了?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/875696430","isVote":1,"tweetType":1,"viewCount":1619,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":855736172,"gmtCreate":1635399822836,"gmtModify":1635399822836,"author":{"id":"4090325469879100","authorId":"4090325469879100","name":"摩尔拉雅","avatar":"https://static.tigerbbs.com/108215f4a8df4e441e706ff3b91022fa","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090325469879100","authorIdStr":"4090325469879100"},"themes":[],"htmlText":"这篇文章不错,转发给大家看","listText":"这篇文章不错,转发给大家看","text":"这篇文章不错,转发给大家看","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/855736172","repostId":"853292692","repostType":1,"repost":{"id":853292692,"gmtCreate":1634811243715,"gmtModify":1634811243715,"author":{"id":"3520120256277227","authorId":"3520120256277227","name":"雷递","avatar":"https://static.tigerbbs.com/c1d76d196de1b078825d97644631d0f1","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3520120256277227","authorIdStr":"3520120256277227"},"themes":[],"title":"先通医药完成3.2亿元融资 国寿大健康基金和大钲资本领投","htmlText":"雷递网 乐天 10月21日报道北京先通国际医药科技股份有限公司(下称“先通医药”)宣布完成3.2亿元D+轮融资。本轮融资由新进投资机构国寿大健康基金和大钲资本共同投资,现有股东盼亚投资、得怡资本等继续跟投。此前公司刚刚完成D轮融资,自2020年4月至今不到一年半时间,公司连续完成总额约10亿元融资。先通医药称,此次募集资金将继续用于放射性新药项目的临床研究和开发。先通医药是专注新一代放射性药物研发、生产及临床应用的创新型医药企业,深耕放射性靶向诊疗一体化系列丰沛产品线。总部位于首都北京,同时在江苏、广东、四川拥有现代化放射性药物生产基地,美国拥有分支机构。公司依托全球领先的放射性药物和精准诊疗领域研发资源,在肿瘤、神经退行性疾病和心血管等领域已率先布局多款靶向治疗和精准诊断放射性药物;依托自主研发团队强大的研发能力,目前公司管线已布局多个放射性诊断和治疗产品,部分进入注册临床研究阶段。随着近年来放射性同位素的靶向性临床应用,全球放射性药物市场规模增长迅速,2020年为71亿美元,预计2030年将达到260亿美元。与此同时随着国内纲领性产业文件的发布、放射性药物适用于MAH制度、核医学设备配置证的放开,国内的放射药市场也将迎来蓬勃发展。先通医药创始人、董事长徐新盛表示:“随着核医学领域国家中长期发展规划的出台,国内放射性药物领域的发展开始步入快车道。我国的核医学领域尚处在发展早期阶段,先通依靠较强的自主研发能力,同时与国际上的先进核药企业开展合作,全力推进放射药品的研发,为广大患者和核医学界同仁提供充足的弹药。”徐新盛说:“我们相信在优质资本的助力下,与合作伙伴共同努力,将先通打造成国内放射药细分领域的领先企业,为中国放射药行业的崛起贡献一份力量。”———————————————雷递由资深媒体人雷建平创办,若转载请写明来源。","listText":"雷递网 乐天 10月21日报道北京先通国际医药科技股份有限公司(下称“先通医药”)宣布完成3.2亿元D+轮融资。本轮融资由新进投资机构国寿大健康基金和大钲资本共同投资,现有股东盼亚投资、得怡资本等继续跟投。此前公司刚刚完成D轮融资,自2020年4月至今不到一年半时间,公司连续完成总额约10亿元融资。先通医药称,此次募集资金将继续用于放射性新药项目的临床研究和开发。先通医药是专注新一代放射性药物研发、生产及临床应用的创新型医药企业,深耕放射性靶向诊疗一体化系列丰沛产品线。总部位于首都北京,同时在江苏、广东、四川拥有现代化放射性药物生产基地,美国拥有分支机构。公司依托全球领先的放射性药物和精准诊疗领域研发资源,在肿瘤、神经退行性疾病和心血管等领域已率先布局多款靶向治疗和精准诊断放射性药物;依托自主研发团队强大的研发能力,目前公司管线已布局多个放射性诊断和治疗产品,部分进入注册临床研究阶段。随着近年来放射性同位素的靶向性临床应用,全球放射性药物市场规模增长迅速,2020年为71亿美元,预计2030年将达到260亿美元。与此同时随着国内纲领性产业文件的发布、放射性药物适用于MAH制度、核医学设备配置证的放开,国内的放射药市场也将迎来蓬勃发展。先通医药创始人、董事长徐新盛表示:“随着核医学领域国家中长期发展规划的出台,国内放射性药物领域的发展开始步入快车道。我国的核医学领域尚处在发展早期阶段,先通依靠较强的自主研发能力,同时与国际上的先进核药企业开展合作,全力推进放射药品的研发,为广大患者和核医学界同仁提供充足的弹药。”徐新盛说:“我们相信在优质资本的助力下,与合作伙伴共同努力,将先通打造成国内放射药细分领域的领先企业,为中国放射药行业的崛起贡献一份力量。”———————————————雷递由资深媒体人雷建平创办,若转载请写明来源。","text":"雷递网 乐天 10月21日报道北京先通国际医药科技股份有限公司(下称“先通医药”)宣布完成3.2亿元D+轮融资。本轮融资由新进投资机构国寿大健康基金和大钲资本共同投资,现有股东盼亚投资、得怡资本等继续跟投。此前公司刚刚完成D轮融资,自2020年4月至今不到一年半时间,公司连续完成总额约10亿元融资。先通医药称,此次募集资金将继续用于放射性新药项目的临床研究和开发。先通医药是专注新一代放射性药物研发、生产及临床应用的创新型医药企业,深耕放射性靶向诊疗一体化系列丰沛产品线。总部位于首都北京,同时在江苏、广东、四川拥有现代化放射性药物生产基地,美国拥有分支机构。公司依托全球领先的放射性药物和精准诊疗领域研发资源,在肿瘤、神经退行性疾病和心血管等领域已率先布局多款靶向治疗和精准诊断放射性药物;依托自主研发团队强大的研发能力,目前公司管线已布局多个放射性诊断和治疗产品,部分进入注册临床研究阶段。随着近年来放射性同位素的靶向性临床应用,全球放射性药物市场规模增长迅速,2020年为71亿美元,预计2030年将达到260亿美元。与此同时随着国内纲领性产业文件的发布、放射性药物适用于MAH制度、核医学设备配置证的放开,国内的放射药市场也将迎来蓬勃发展。先通医药创始人、董事长徐新盛表示:“随着核医学领域国家中长期发展规划的出台,国内放射性药物领域的发展开始步入快车道。我国的核医学领域尚处在发展早期阶段,先通依靠较强的自主研发能力,同时与国际上的先进核药企业开展合作,全力推进放射药品的研发,为广大患者和核医学界同仁提供充足的弹药。”徐新盛说:“我们相信在优质资本的助力下,与合作伙伴共同努力,将先通打造成国内放射药细分领域的领先企业,为中国放射药行业的崛起贡献一份力量。”———————————————雷递由资深媒体人雷建平创办,若转载请写明来源。","images":[{"img":"https://static.tigerbbs.com/1e412d5fe338ad36aa0a8dde63455c4f"}],"top":1,"highlighted":1,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/853292692","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":851,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":855736346,"gmtCreate":1635399815870,"gmtModify":1635399815870,"author":{"id":"4090325469879100","authorId":"4090325469879100","name":"摩尔拉雅","avatar":"https://static.tigerbbs.com/108215f4a8df4e441e706ff3b91022fa","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090325469879100","authorIdStr":"4090325469879100"},"themes":[],"htmlText":"这篇文章不错,转发给大家看","listText":"这篇文章不错,转发给大家看","text":"这篇文章不错,转发给大家看","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/855736346","repostId":"851122079","repostType":1,"repost":{"id":851122079,"gmtCreate":1634883866090,"gmtModify":1634884068988,"author":{"id":"3556666140891757","authorId":"3556666140891757","name":"紫荆财智","avatar":"https://static.tigerbbs.com/9be2735744f718237d3b5ef362758bb9","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3556666140891757","authorIdStr":"3556666140891757"},"themes":[],"title":"国寿走势转强可续跟进","htmlText":"中资保险股昨日成为市场热捧的焦点之一,尤其是下周三派发成绩表的中国平安(2318),见偷步炒上,收报62.75元,升7.54%,为表现最突出的蓝筹股之一。同属一线内险股的中国人寿(2628)昨日亦跟随同业造好,曾高见14.5元,乃为7月7日以来高位,收报14.28元,仍升0.3元或2.15%,现价已企稳于多条重要平均线之上。国寿已定于下周四(28日)公布第三季业绩,观乎集团最近公布的保费收入保持平稳的增长势头,加上早前派发的中期颇为对办,预计季续也不会令市场失望。国寿较早前公布上半年业绩,录得纯利按年上升34.19%至409.75亿元(人民币,下同),主要由总投资收益上升带动,期内总投资收益率为5.69% ,按年上升0.35个百分点,总投资收益按年上升22.37%至1176.38亿元。至于反映未来盈利能力的新业务价值,按年跌19.04% 至298.67 亿元( 人民币,下同),新单保费按年下跌8.41% 至1,339.14 亿元,主要业务个人保险渠道的新业务价值率,按年下跌3.1 个百分点至36.2% 。国寿解释,外部经营环境复杂多变,加上新冠疫情影响保险消费需求释放,行业复苏发展面临多重挑战。国寿首年期交保费按年下跌14.3% 至806.74 亿元,其中利润较高的10 年期及以上首年期交保费,按年下降26.7% 至289.40 亿元,下跌主要来自寿险业务。最新的营运数据显示,集团首九个月原保费收入为5,534亿元,按年增1.8%。该股预测市盈率5.33倍,低于平保的6.7倍,市账率0.75倍,亦低于平保的1.26倍。在股价走势转好下,其下一个目标将上移至16元(港元,下同),惟失守20天线支持的13.45元则止蚀。看好国寿留意购轮26466若看好国寿后市升势延续,可留意国寿中银购轮(26466)。26466昨收0.241元,其于明年5月16日最后买卖,行使价15.02元,","listText":"中资保险股昨日成为市场热捧的焦点之一,尤其是下周三派发成绩表的中国平安(2318),见偷步炒上,收报62.75元,升7.54%,为表现最突出的蓝筹股之一。同属一线内险股的中国人寿(2628)昨日亦跟随同业造好,曾高见14.5元,乃为7月7日以来高位,收报14.28元,仍升0.3元或2.15%,现价已企稳于多条重要平均线之上。国寿已定于下周四(28日)公布第三季业绩,观乎集团最近公布的保费收入保持平稳的增长势头,加上早前派发的中期颇为对办,预计季续也不会令市场失望。国寿较早前公布上半年业绩,录得纯利按年上升34.19%至409.75亿元(人民币,下同),主要由总投资收益上升带动,期内总投资收益率为5.69% ,按年上升0.35个百分点,总投资收益按年上升22.37%至1176.38亿元。至于反映未来盈利能力的新业务价值,按年跌19.04% 至298.67 亿元( 人民币,下同),新单保费按年下跌8.41% 至1,339.14 亿元,主要业务个人保险渠道的新业务价值率,按年下跌3.1 个百分点至36.2% 。国寿解释,外部经营环境复杂多变,加上新冠疫情影响保险消费需求释放,行业复苏发展面临多重挑战。国寿首年期交保费按年下跌14.3% 至806.74 亿元,其中利润较高的10 年期及以上首年期交保费,按年下降26.7% 至289.40 亿元,下跌主要来自寿险业务。最新的营运数据显示,集团首九个月原保费收入为5,534亿元,按年增1.8%。该股预测市盈率5.33倍,低于平保的6.7倍,市账率0.75倍,亦低于平保的1.26倍。在股价走势转好下,其下一个目标将上移至16元(港元,下同),惟失守20天线支持的13.45元则止蚀。看好国寿留意购轮26466若看好国寿后市升势延续,可留意国寿中银购轮(26466)。26466昨收0.241元,其于明年5月16日最后买卖,行使价15.02元,","text":"中资保险股昨日成为市场热捧的焦点之一,尤其是下周三派发成绩表的中国平安(2318),见偷步炒上,收报62.75元,升7.54%,为表现最突出的蓝筹股之一。同属一线内险股的中国人寿(2628)昨日亦跟随同业造好,曾高见14.5元,乃为7月7日以来高位,收报14.28元,仍升0.3元或2.15%,现价已企稳于多条重要平均线之上。国寿已定于下周四(28日)公布第三季业绩,观乎集团最近公布的保费收入保持平稳的增长势头,加上早前派发的中期颇为对办,预计季续也不会令市场失望。国寿较早前公布上半年业绩,录得纯利按年上升34.19%至409.75亿元(人民币,下同),主要由总投资收益上升带动,期内总投资收益率为5.69% ,按年上升0.35个百分点,总投资收益按年上升22.37%至1176.38亿元。至于反映未来盈利能力的新业务价值,按年跌19.04% 至298.67 亿元( 人民币,下同),新单保费按年下跌8.41% 至1,339.14 亿元,主要业务个人保险渠道的新业务价值率,按年下跌3.1 个百分点至36.2% 。国寿解释,外部经营环境复杂多变,加上新冠疫情影响保险消费需求释放,行业复苏发展面临多重挑战。国寿首年期交保费按年下跌14.3% 至806.74 亿元,其中利润较高的10 年期及以上首年期交保费,按年下降26.7% 至289.40 亿元,下跌主要来自寿险业务。最新的营运数据显示,集团首九个月原保费收入为5,534亿元,按年增1.8%。该股预测市盈率5.33倍,低于平保的6.7倍,市账率0.75倍,亦低于平保的1.26倍。在股价走势转好下,其下一个目标将上移至16元(港元,下同),惟失守20天线支持的13.45元则止蚀。看好国寿留意购轮26466若看好国寿后市升势延续,可留意国寿中银购轮(26466)。26466昨收0.241元,其于明年5月16日最后买卖,行使价15.02元,","images":[{"img":"https://static.tigerbbs.com/01b4136dcc2068934838b7c063139597"}],"top":1,"highlighted":1,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/851122079","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":734,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":820042910,"gmtCreate":1633331871863,"gmtModify":1633331871863,"author":{"id":"4090325469879100","authorId":"4090325469879100","name":"摩尔拉雅","avatar":"https://static.tigerbbs.com/108215f4a8df4e441e706ff3b91022fa","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090325469879100","authorIdStr":"4090325469879100"},"themes":[],"htmlText":"这篇文章不错,转发给大家看","listText":"这篇文章不错,转发给大家看","text":"这篇文章不错,转发给大家看","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/820042910","repostId":"2172396270","repostType":4,"isVote":1,"tweetType":1,"viewCount":307,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":820046762,"gmtCreate":1633331844220,"gmtModify":1633331844220,"author":{"id":"4090325469879100","authorId":"4090325469879100","name":"摩尔拉雅","avatar":"https://static.tigerbbs.com/108215f4a8df4e441e706ff3b91022fa","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090325469879100","authorIdStr":"4090325469879100"},"themes":[],"htmlText":"应该应该吧","listText":"应该应该吧","text":"应该应该吧","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/820046762","repostId":"2172998592","repostType":4,"isVote":1,"tweetType":1,"viewCount":236,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":820046522,"gmtCreate":1633331815586,"gmtModify":1633331815586,"author":{"id":"4090325469879100","authorId":"4090325469879100","name":"摩尔拉雅","avatar":"https://static.tigerbbs.com/108215f4a8df4e441e706ff3b91022fa","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090325469879100","authorIdStr":"4090325469879100"},"themes":[],"htmlText":"是吗?","listText":"是吗?","text":"是吗?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/820046522","repostId":"2172998592","repostType":4,"isVote":1,"tweetType":1,"viewCount":406,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}